Publication
International arbitration report
In this edition, we focused on the Shanghai International Economic and Trade Arbitration Commission’s (SHIAC) new arbitration rules, which take effect January 1, 2024.
United States | Publication | April 2022
Currently pending before the California Senate is SB 1044, a bill that would allow employees to refuse to come to work, or to walk off the job, whenever they feel unsafe or whenever there is a declared state of emergency. The bill also would prohibit employers from preventing employees from using their mobile devices during an emergency. The most recent amendments to the bill partially address employer concerns about the scope of the bill. Nevertheless, the bill would create an additional exception to at-will employment and has been labeled a “job-killer” by the California Chamber of Commerce.
The key provisions of the bill are as follows:
In the event of a state of emergency or an emergency condition, an employer shall not do either of the following:
(1) Take or threaten adverse action against any employee refusing to report to, or leaving, a workplace within the affected area because the employee feels unsafe.
(2) Prevent any employee from accessing the employee’s mobile device or other communications device for seeking emergency assistance, assessing the safety of the situation, or communicating with a person to verify their safety.
Publication
In this edition, we focused on the Shanghai International Economic and Trade Arbitration Commission’s (SHIAC) new arbitration rules, which take effect January 1, 2024.
Publication
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Publication
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023